Gastrointestinal Endoscopy Devices | Market Insights | US | 2024
The GI endoscopy device market in the US has experienced short-term challenges due to the COVID-19 pandemic. Nevertheless, there are signs of a robust recovery and projected moderate expansion until 2032. New treatment and screening guidelines, along with the availability of alternative tests, are expected to drive growth of procedure volumes across the country. The market is also witnessing the adoption of single-use duodenoscopes to address contamination concerns, although recent developments have highlighted issues with these components. Furthermore, the growing integration of AI in GI videoscope systems is poised to foster overall market growth. Despite these positive trends, factors such as accelerated hospital consolidation, reimbursement changes, and the shift toward value-based care may impose limitations on the market’s overall growth trajectory.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for GI endoscopy devices in the US from 2019 to 2032.
